Steven Gunzler

Dr. Steven Gunzler


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2021 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
AKAnastasia Kuzkina
Anastasia Kuzkina
CBConnor Bargar
Connor Bargar
DSDaniela Schmitt
Daniela Schmitt
JRJonas Rößle
Jonas Rößle
WWWen Wang
Wen Wang
SCShu G. Chen
Shu G. Chen
Skin α-synuclein deposition is considered a potential biomarker for Parkinson’s disease (PD). Real-time quaking-induced conversion (RT-QuIC) is a novel, ultrasensitive, and efficient seeding assay that enables the detection of minute amounts of α-synuclein aggregates. We aimed to determine the diagnostic accuracy, reliability, and reproducibility of α-synuclein RT-QuIC assay of skin biopsy for diagnosing PD and to explore its correlation with clinical markers of PD in a two-center inter-laboratory comparison study. Patients with clinically diagnosed PD (n = 34), as well as control subjects (n = 30), underwent skin punch biopsy at multiple sites (neck, lower back, thigh, and lower leg). The skin biopsy samples (198 in total) were divided in half to be analyzed by RT-QuIC assay in two independent laboratories. The α-synuclein RT-QuIC assay of multiple skin biopsies supported the clinical diagnosis of PD with a diagnostic accuracy of 88.9% and showed a high degree of inter-rater agreement between the two laboratories (92.2%). Higher α-synuclein seeding activity in RT-QuIC was shown in patients with longer disease duration and more advanced disease stage and correlated with the presence of REM sleep behavior disorder, cognitive impairment, and constipation. The α-synuclein RT-QuIC assay of minimally invasive skin punch biopsy is a reliable and reproducible biomarker for Parkinson’s disease. Moreover, α-synuclein RT-QuIC seeding activity in the skin may serve as a potential indicator of progression as it correlates with the disease stage and certain non-motor symptoms.

15 October 2008 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
JNJohn G. Nutt
John G. Nutt
SGSteven Gunzler
Steven Gunzler
TKTrish Kirchhoff
Trish Kirchhoff
PHPenelope Hogarth
Penelope Hogarth
JWJerry L. Weaver
Jerry L. Weaver
JLJaren W. Landen
Jaren W. Landen

11 December 2021 in Molecular Neurodegeneration
Verified
Journal Article
Open access
PDF file
CBConnor Bargar
Connor Bargar
CLChiara Maria Giulia De Luca
Chiara Maria Giulia De Luca
GDGrazia Devigili
Grazia Devigili
AEAntonio Emanuele Elia
Antonio Emanuele Elia
Roberto CiliaRoberto Cilia
Roberto Cilia
FMFabio Moda
Fabio Moda
Background: Detection of the pathological and disease-associated alpha-synuclein (αSynD) in the brain is required to formulate the definitive diagnosis of multiple system atrophy (MSA) and Parkinson’s disease (PD). We recently showed that αSynD can be detected in the olfactory mucosa (OM) of MSA and PD patients. For this reason, we have performed the first interlaboratory study based on α-synuclein Real-Time Quaking-Induced Conversion (αSyn_RT-QuIC) analysis of OM samples collected from PD and MSA patients with the parkinsonian (MSA-P) and cerebellar (MSA-C) phenotypes. Methods: OM samples were prospectively collected from patients with a probable diagnosis of MSA-P (n = 20, mean disease duration 4.4 years), MSA-C (n = 10, mean disease duration 4 years), PD (n = 13, mean disease duration 8 years), and healthy control subjects (HS) (n = 11). Each sample was analyzed by αSyn_RT-QuIC in two independent specialized laboratories, one located in Italy (ITA-lab) and one located in the USA (USA-lab). Both laboratories have developed and used harmonized αSyn_RT-QuIC analytical procedures. Results were correlated with demographic and clinical data. Results: The αSyn_RT-QuIC analysis reached a 96% interrater agreement of results (IAR) between laboratories (Kappa = 0.93, 95% CI 0.83–1.00). In particular, αSyn_RT-QuIC seeding activity was found in the OM of 9/13 patients with PD (sensitivity 69%, IAR 100%) and 18/20 patients with MSA-P (sensitivity 90%, IAR 100%). Interestingly, samples collected from patients with MSA-C did not induce αSyn_RT-QuIC seeding activity, except for one subject in USA-lab. Therefore, we found that MSA-P and MSA-C induced opposite effects. Regardless of disease diagnosis, the αSyn_RT-QuIC seeding activity correlated with some clinical parameters, including the rigidity and postural instability. Conclusions: Our study provides evidence that OM-αSynD may serve as a novel biomarker for accurate clinical diagnoses of PD, MSA-P, and MSA-C. Moreover, αSyn_RT-QuIC represents a reliable assay that can distinguish patients with MSA-P from those with MSA-C, and may lead to significant advancements in patients stratification and selection for emerging pharmacological treatments and clinical trials.

1 May 2017 in Patient Preference and Adherence
Verified
Journal Article
Open access
PDF file
MSMartha Sajatovic
Martha Sajatovic
ARAngela L. Ridgel
Angela L. Ridgel
EWEllen M Walter
Ellen M Walter
CTCurtis M Tatsuoka
Curtis M Tatsuoka
KCKari Colon-Zimmermann
Kari Colon-Zimmermann
BWBenjamin L Walter
Benjamin L Walter
Background: Depression is common in people with Parkinson’s disease (PD), and exercise is known to improve depression and PD. However, lack of motivation and low self-efficacy can make exercise difficult for people with PD and comorbid depression (PD-Dep). A combined group exercise and chronic disease self-management (CDSM) program may improve the likelihood that individuals will engage in exercise and will show a reduction in depression symptoms. The purpose of this study was to compare changes in depression in PD-Dep between individual versus group exercise plus CDSM and to examine participant adherence and perception of the interventions. Methods: Participants (N=30) were randomized to either Enhanced EXerCisE thErapy for PD (EXCEED; group CDSM and exercise) or self-guided CDSM plus exercise. Outcomes were change in depression assessed with the Montgomery–Asberg Depression Rating Scale (MADRS), cognition, apathy, anxiety, sleep, quality of life, motor function, self-efficacy, and patient satisfaction. Results: Both groups showed significant improvement in MADRS (P<0.001) with no significant group difference. Individuals in EXCEED group enjoyed the group dynamics but noted difficulty with the fixed-time sessions. Conclusion: Both group CDSM plus exercise and self-guided CDSM plus exercise can improve depression in PD-Dep. These findings suggest that development of a remotely delivered group-based CDSM format plus manualized exercise program could be useful for this population.

1 August 2012
Verified
Conference Paper
Closed access
DHDustin A. Heldman
Dustin A. Heldman
DFDanielle E. Filipkowski
Danielle E. Filipkowski
DRDavid E. Riley
David E. Riley
CWChristina M. Whitney
Christina M. Whitney
BWBenjamin L Walter
Benjamin L Walter
TMThomas O. Mera
Thomas O. Mera
The objective was to develop and evaluate algorithms for quantifying gait and lower extremity bradykinesia in patients with Parkinson's disease using kinematic data recorded on a heel-worn motion sensor unit. Subjects were evaluated by three movement disorder neurologists on four domains taken from the Movement Disorders Society Unified Parkinson's Disease Rating Scale while wearing the motion sensor unit. Multiple linear regression models were developed based on the recorded kinematic data and clinician scores and produced outputs highly correlated to clinician scores with an average correlation coefficient of 0.86. The newly developed models have been integrated into a home-based system for monitoring Parkinson's disease motor symptoms.

1 May 2013 in Gait & Posture
Verified
Journal Article
Closed access
TMThomas O. Mera
Thomas O. Mera
DFDanielle E. Filipkowski
Danielle E. Filipkowski
DRDavid E. Riley
David E. Riley
CWChristina M. Whitney
Christina M. Whitney
BWBenjamin L Walter
Benjamin L Walter
JGJoseph P. Giuffrida
Joseph P. Giuffrida